The Potential of Ibrutinib Combinations for the Treatment of CLL

Video

Javier Pinilla-Ibarz, MD, PhD, associate member, Malignant Hematology and Immunology Program at the H. Lee Moffitt Cancer Center, discusses ongoing research with ibrutinib (Imbruvica) in chronic lymphocytic leukemia. 

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content